DUBLIN, Nov. 25, 2020 /PRNewswire/ -- The "Global Biomaterials Market By Product (Implants, Valves, Joint Replacement, Contact Lenses and Others), By Material Type (Metallic, Natural, Ceramics, Polymeric, Living Cell and Tissue), By Type, By Application, By End User, By Region, Forecast & Opportunities, 2025" report has been added to ResearchAndMarkets.com's offering.
The Global Biomaterials Market is expected to register substantial rate of growth during the forecast period owing to factors like increasing geriatric population, rapidly growing healthcare sector and its wider use in various products and applications, such as contact lenses, skin repair, blood vessel prosthesis, gene transfer, drug delivery, and dental.
Biomaterials are artificially derived synthetic or natural materials which are used to interact with biological systems for medical purposes and treatments. They are often used in medical applications to augment or replace a natural function. The biomaterial market is anticipated to grow significantly during the next five years due to discoveries in tissue engineering, regenerative medicine, and more. They often are biodegradable, and some are bio-absorbable, meaning they are eliminated gradually from the body after fulfilling a function. Additionally, metals, ceramics, plastic, glass, and even living cells and tissue all can be used in creating a biomaterial. Moreover, heavy funding by government organizations for innovation of new products is creating new scope for the growth in biomaterials market. Rising prevalence of cardiovascular, neurological, & orthopedic disorders, coupled with increasing awareness regarding the advantages of biomaterials products is further driving the market. Furthermore, rising prevalence of cardiovascular, neurological, & orthopedic disorders around the world is anticipated to create major demand for biomaterials through 2025.
The Global Biomaterials Market is segmented based on product, material type, type, application, end-user, and region. Based on material type, the market is segmented into metallic, natural, ceramics, polymeric, living cell and tissue. The metallic biomaterials segment held lion's share in 2019 due to wide use of metals in the manufacturing of medical devices and their use in orthopedic procedures for bone support and replacement, as they are strong and resistant to fatigue degradation.
By region, North America dominates the biomaterials market owing to the initiatives undertaken by several public and private organizations in the region. Also, factors such as favorable government policies and presence of major market players made the region dominant in terms of revenue share in 2019. However, Asia-Pacific region is expected to register highest CAGR in the coming years due to a large population base in countries like India and China coupled with growing incidences of chronic diseases and rising awareness about biomaterials in the region.
Objective of the Study:
Key Topics Covered:
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Biomaterials Market
4. Executive Summary
5. Global Biomaterials Market Outlook5.1. Market Size & Forecast5.1.1. By Value & Volume5.2. Market Share & Forecast5.2.1. By Product (Implants, Valves, Joint Replacement, Contact Lenses and Others)5.2.2. By Material Type (Metallic, Natural, Ceramics, Polymeric, Living Cell and Tissue)5.2.3. By Type (Bioinert, Bioresorbable, Bio Tolerant and Bioactive)5.2.4. By Application (Ophthalmology, Cardiovascular, Orthopedic, Wound Healing, Plastic Surgery, Neurology, Dental, Others)5.2.5. By End User (Private Hospitals, Government Hospitals, Specialty Clinics)5.2.6. By Company (2019)5.2.7. By Region5.3. Market Attractiveness Index
6. Asia-Pacific Biomaterials Market Outlook6.1. Market Size & Forecast6.1.1. By Value & Volume6.2. Market Share & Forecast6.2.1. By Material Type6.2.2. By Application6.2.3. By Country6.3. Market Attractiveness Index6.4. Asia-Pacific: Country Analysis6.4.1. China Biomaterials Market Outlook6.4.1.1. Market Size & Forecast6.4.1.1.1. By Value6.4.1.2. Market Share & Forecast6.4.1.2.1. By Material Type6.4.1.2.2. By Application6.4.2. India Biomaterials Market Outlook6.4.2.1. Market Size & Forecast6.4.2.1.1. By Value6.4.2.2. Market Share & Forecast6.4.2.2.1. By Material Type6.4.2.2.2. By Application6.4.3. Japan Biomaterials Market Outlook6.4.3.1. Market Size & Forecast6.4.3.1.1. By Value6.4.3.2. Market Share & Forecast6.4.3.2.1. By Material Type6.4.3.2.2. By Application6.4.4. South Korea Biomaterials Market Outlook6.4.4.1. Market Size & Forecast6.4.4.1.1. By Value6.4.4.2. Market Share & Forecast6.4.4.2.1. By Material Type6.4.4.2.2. By Application6.4.5. Singapore Biomaterials Market Outlook6.4.5.1. Market Size & Forecast6.4.5.1.1. By Value6.4.5.2. Market Share & Forecast6.4.5.2.1. By Material Type6.4.5.2.2. By Application6.4.6. Australia Biomaterials Market Outlook6.4.6.1. Market Size & Forecast6.4.6.1.1. By Value6.4.6.2. Market Share & Forecast6.4.6.2.1. By Material Type6.4.6.2.2. By Application
7. Europe Biomaterials Market Outlook7.1. Market Size & Forecast7.1.1. By Value & Volume7.2. Market Share & Forecast7.2.1. By Material Type7.2.2. By Application7.2.3. By Country7.3. Market Attractiveness Index7.4. Europe: Country Analysis7.4.1. France Biomaterials Market Outlook7.4.1.1. Market Size & Forecast7.4.1.1.1. By Value7.4.1.2. Market Share & Forecast7.4.1.2.1. By Material Type7.4.1.2.2. By Application7.4.2. Germany Biomaterials Market Outlook7.4.2.1. Market Size & Forecast7.4.2.1.1. By Value7.4.2.2. Market Share & Forecast7.4.2.2.1. By Material Type7.4.2.2.2. By Application7.4.3. United Kingdom Biomaterials Market Outlook7.4.3.1. Market Size & Forecast7.4.3.1.1. By Value7.4.3.2. Market Share & Forecast7.4.3.2.1. By Material Type7.4.3.2.2. By Application7.4.4. Italy Biomaterials Market Outlook7.4.4.1. Market Size & Forecast7.4.4.1.1. By Value7.4.4.2. Market Share & Forecast7.4.4.2.1. By Material Type7.4.4.2.2. By Application7.4.4.2.3. By End User
8. North America Biomaterials Market Outlook8.1. Market Size & Forecast8.1.1. By Value & Volume8.2. Market Share & Forecast8.2.1. By Material Type8.2.2. By Application8.2.3. By Country8.3. Market Attractiveness Index8.4. North America: Country Analysis8.4.1. United States Biomaterials Market Outlook8.4.1.1. Market Size & Forecast8.4.1.1.1. By Value8.4.1.2. Market Share & Forecast8.4.1.2.1. By Material Type8.4.1.2.2. By Application8.4.2. Mexico Biomaterials Market Outlook8.4.2.1. Market Size & Forecast8.4.2.1.1. By Value8.4.2.2. Market Share & Forecast8.4.2.2.1. By Material Type8.4.2.2.2. By Application8.4.3. Canada Biomaterials Market Outlook8.4.3.1. Market Size & Forecast8.4.3.1.1. By Value8.4.3.2. Market Share & Forecast8.4.3.2.1. By Material Type8.4.3.2.2. By Application
9. South America Biomaterials Market Outlook9.1. Market Size & Forecast9.1.1. By Value & Volume9.2. Market Share & Forecast9.2.1. By Material Type9.2.2. By Application9.2.3. By Country9.3. Market Attractiveness Index9.4. South America: Country Analysis9.4.1. Brazil Biomaterials Market Outlook9.4.1.1. Market Size & Forecast9.4.1.1.1. By Value9.4.1.2. Market Share & Forecast9.4.1.2.1. By Material Type9.4.1.2.2. By Application9.4.2. Argentina Biomaterials Market Outlook9.4.2.1. Market Size & Forecast9.4.2.1.1. By Value9.4.2.2. Market Share & Forecast9.4.2.2.1. By Material Type9.4.2.2.2. By Application9.4.3. Colombia Biomaterials Market Outlook9.4.3.1. Market Size & Forecast9.4.3.1.1. By Value9.4.3.2. Market Share & Forecast9.4.3.2.1. By Material Type9.4.3.2.2. By Application
10. Middle East and Africa Biomaterials Market Outlook10.1. Market Size & Forecast10.1.1. By Value & Volume10.2. Market Share & Forecast10.2.1. By Material Type10.2.2. By Application10.2.3. By Country10.3. Market Attractiveness Index10.4. MEA: Country Analysis10.4.1. South Africa Biomaterials Market Outlook10.4.1.1. Market Size & Forecast10.4.1.1.1. By Value10.4.1.2. Market Share & Forecast10.4.1.2.1. By Material Type10.4.1.2.2. By Application10.4.2. Saudi Arabia Biomaterials Market Outlook10.4.2.1. Market Size & Forecast10.4.2.1.1. By Value10.4.2.2. Market Share & Forecast10.4.2.2.1. By Material Type10.4.2.2.2. By Application10.4.3. UAE Biomaterials Market Outlook10.4.3.1. Market Size & Forecast10.4.3.1.1. By Value10.4.3.2. Market Share & Forecast10.4.3.2.1. By Material Type10.4.3.2.2. By Application
11. Market Dynamics11.1. Drivers11.2. Challenges
12. Market Trends & Developments
13. Competitive Landscape13.1. Competition Outlook13.2. Players Profiled (Leading Companies)13.2.1. Koninklijke DSM N.V.13.2.2. Bayer AG13.2.3. Corbion NV13.2.4. Wright Medical Technology, Inc.13.2.5. Zimmer Biomet Holdings, Inc.13.2.6. Collagen Matrix, Inc.13.2.7. Noble Biomaterials Inc13.2.8. Covalon Technologies Ltd13.2.9. Olympus corporation13.2.10. Johnson & Johnson13.2.11. Cook Medical13.2.12. Smith and Nephew13.2.13. Becton Dickinson13.2.14. Medtronic13.2.15. Angiodynamics
14. Strategic Recommendations
15. About Us & Disclaimer
For more information about this report visit https://www.researchandmarkets.com/r/j7yiqc
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets Laura Wood, Senior Manager [emailprotected]
For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
http://www.researchandmarkets.com
See more here:
Insights on the Biomaterials Global Market to 2025 - Forecast and Opportunities - PRNewswire
- 001 Stem cells for a Webby! [Last Updated On: April 28th, 2010] [Originally Added On: April 28th, 2010]
- 002 Stem cells for a Webby! [Last Updated On: April 28th, 2010] [Originally Added On: April 28th, 2010]
- 003 Latest Cell Therapy Approval by FDA. Dendreon's Provenge. [Last Updated On: April 30th, 2010] [Originally Added On: April 30th, 2010]
- 004 Latest Cell Therapy Approval by FDA. Dendreon's Provenge. [Last Updated On: April 30th, 2010] [Originally Added On: April 30th, 2010]
- 005 Google to Invest in Regenerative Medicine [Last Updated On: May 5th, 2010] [Originally Added On: May 5th, 2010]
- 006 Biotech tax credit appears perfectly designed for cell therapy companies to recoup research dollars spent in 2009-10 [Last Updated On: May 22nd, 2010] [Originally Added On: May 22nd, 2010]
- 007 The changing face of PR and why it matters to regenmed [Last Updated On: June 12th, 2010] [Originally Added On: June 12th, 2010]
- 008 The changing face of PR and why it matters to regenmed [Last Updated On: June 12th, 2010] [Originally Added On: June 12th, 2010]
- 009 Stem Cell Therapy: Age of Human Cell Engineering is Born [Last Updated On: June 25th, 2010] [Originally Added On: June 25th, 2010]
- 010 Using Stem Cells Scientists Grow a Rat Lung, Humans are Next [Last Updated On: June 29th, 2010] [Originally Added On: June 29th, 2010]
- 011 FDA files injunction again Regenerative Sciences citing Regenexx violates regulations [Last Updated On: August 12th, 2010] [Originally Added On: August 12th, 2010]
- 012 FDA files injunction again Regenerative Sciences citing Regenexx violates regulations [Last Updated On: August 12th, 2010] [Originally Added On: August 12th, 2010]
- 013 Careers in cell therapy & regenerative medicine [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 014 Careers in cell therapy & regenerative medicine [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 015 The LinkedIn Cell Therapy Industry Group - 1,000 members strong [Last Updated On: January 18th, 2011] [Originally Added On: January 18th, 2011]
- 016 Cell Therapies: Commercializing a New Class of Biopharmaceuticals [Last Updated On: February 7th, 2011] [Originally Added On: February 7th, 2011]
- 017 The LinkedIn Cell Therapy Industry Group - 1,000 members strong [Last Updated On: February 14th, 2011] [Originally Added On: February 14th, 2011]
- 018 Cell Therapies: Commercializing a New Class of Biopharmaceuticals [Last Updated On: February 14th, 2011] [Originally Added On: February 14th, 2011]
- 019 In vivo cell trafficking just took a leap forward [Last Updated On: July 3rd, 2011] [Originally Added On: July 3rd, 2011]
- 020 In vivo cell trafficking just took a leap forward [Last Updated On: July 3rd, 2011] [Originally Added On: July 3rd, 2011]
- 021 Cell Therapy's Got Talent Technology Showcase - A Call for Cell Therapy Manufacturing Technology Presentations [Last Updated On: July 10th, 2011] [Originally Added On: July 10th, 2011]
- 022 Cell Therapy's Got Talent Technology Showcase - A Call for Cell Therapy Manufacturing Technology Presentations [Last Updated On: July 10th, 2011] [Originally Added On: July 10th, 2011]
- 023 Clinical trial costs [Last Updated On: July 31st, 2011] [Originally Added On: July 31st, 2011]
- 024 Clinical trial costs [Last Updated On: July 31st, 2011] [Originally Added On: July 31st, 2011]
- 025 Good Data? $100. Good Product Development? $100. Good Commercialization Strategy? Priceless. [Last Updated On: August 14th, 2011] [Originally Added On: August 14th, 2011]
- 026 Good Data? $100. Good Product Development? $100. Good Commercialization Strategy? Priceless. [Last Updated On: August 14th, 2011] [Originally Added On: August 14th, 2011]
- 027 Potential far-reaching implications of the ongoing fight over point-of-care autologous cell therapy [Last Updated On: September 18th, 2011] [Originally Added On: September 18th, 2011]
- 028 Commercial-stage Cell Therapy Companies and Products [Last Updated On: September 18th, 2011] [Originally Added On: September 18th, 2011]
- 029 Potential far-reaching implications of the ongoing fight over point-of-care autologous cell therapy [Last Updated On: September 18th, 2011] [Originally Added On: September 18th, 2011]
- 030 Commercial-stage Cell Therapy Companies and Products [Last Updated On: September 18th, 2011] [Originally Added On: September 18th, 2011]
- 031 Cell Therapy & Regenerative Medicine Domains Available [Last Updated On: September 25th, 2011] [Originally Added On: September 25th, 2011]
- 032 Cell Therapy & Regenerative Medicine Domains Available [Last Updated On: September 25th, 2011] [Originally Added On: September 25th, 2011]
- 033 Dr Farshchian: Regenerative Medicine shows Potentials - Video [Last Updated On: October 14th, 2011] [Originally Added On: October 14th, 2011]
- 034 Mayo Clinic Regenerative Medicine Consult Service - Video [Last Updated On: October 16th, 2011] [Originally Added On: October 16th, 2011]
- 035 Regenerative Medicine and Applications of Stem Cell Research - Video [Last Updated On: October 18th, 2011] [Originally Added On: October 18th, 2011]
- 036 The Future of Stem Cells and Regenerative Medicine - Video [Last Updated On: October 18th, 2011] [Originally Added On: October 18th, 2011]
- 037 "You and Your Health" TV Show - Orthopedic Regenerative Medicine - Video [Last Updated On: October 18th, 2011] [Originally Added On: October 18th, 2011]
- 038 Closing Remarks, Screening Stem Cells 2009: From Reprogramming to Regenerative Medicine - Video [Last Updated On: October 18th, 2011] [Originally Added On: October 18th, 2011]
- 039 Hearing Loss Research: CBR Exclusive! Stem Cells Explored as Cure for Hearing Loss - Video [Last Updated On: October 19th, 2011] [Originally Added On: October 19th, 2011]
- 040 An amazing story of stem cells, regenerative medicine and healing power: - Video [Last Updated On: October 19th, 2011] [Originally Added On: October 19th, 2011]
- 041 What is Regenerative Medicine? | Los Angeles | Hollywood | Beverly Hills - Video [Last Updated On: October 19th, 2011] [Originally Added On: October 19th, 2011]
- 042 A New Era in Regenerative Medicine - Video [Last Updated On: October 20th, 2011] [Originally Added On: October 20th, 2011]
- 043 McEwen Centre for Regenerative Medicine - Video [Last Updated On: October 20th, 2011] [Originally Added On: October 20th, 2011]
- 044 Retroviruses, Reproduction, and Regenerative Medicine: The Influence of Federal Funding - Video [Last Updated On: October 21st, 2011] [Originally Added On: October 21st, 2011]
- 045 You and Your Heath TV Show - Orthopedic Regenerative Medicine Part 1 - Video [Last Updated On: October 21st, 2011] [Originally Added On: October 21st, 2011]
- 046 TEDxPhoenix - Jane Maienschein - Stem Cells, Regenerative Medicine and Us - Video [Last Updated On: October 21st, 2011] [Originally Added On: October 21st, 2011]
- 047 Regenerative Medicine: Pathways to Cure - Version 2.0 - Video [Last Updated On: October 21st, 2011] [Originally Added On: October 21st, 2011]
- 048 Opening Remarks, Screening Stem Cells 2009: From Reprogramming to Regenerative Medicine - Video [Last Updated On: October 23rd, 2011] [Originally Added On: October 23rd, 2011]
- 049 Commercializing Cell-based Regenerative Medicines [Last Updated On: November 13th, 2011] [Originally Added On: November 13th, 2011]
- 050 Commercializing Cell-based Regenerative Medicines [Last Updated On: November 13th, 2011] [Originally Added On: November 13th, 2011]
- 051 Coast To Coast AM - 15.11.2011 - 4/4 - Regenerative Medicine/Dulce Base - Video [Last Updated On: November 17th, 2011] [Originally Added On: November 17th, 2011]
- 052 Coast To Coast AM - 15.11.2011 - 1/4 - Regenerative Medicine/Dulce Base - Video [Last Updated On: November 17th, 2011] [Originally Added On: November 17th, 2011]
- 053 Stem Cell Based Therapies for Blindness: David Hinton - CIRM Science Writer's Seminar - Video [Last Updated On: November 18th, 2011] [Originally Added On: November 18th, 2011]
- 054 Dr. Craig Saunders Discusses Stem Cells and Regenerative Medicine at the Evolution of Fat Workshop - Video [Last Updated On: November 24th, 2011] [Originally Added On: November 24th, 2011]
- 055 Coast To Coast AM: Regenerative Medicine / Dulce Base 11-15-2011 Download Link - Video [Last Updated On: November 24th, 2011] [Originally Added On: November 24th, 2011]
- 056 Sabrina Cohen Foundation Thanks Stem Cell Researchers [Last Updated On: November 27th, 2011] [Originally Added On: November 27th, 2011]
- 057 Sabrina Cohen Foundation Thanks Stem Cell Researchers [Last Updated On: November 27th, 2011] [Originally Added On: November 27th, 2011]
- 058 StemCellTV Talks to Elona Baum of the California Institute of Regenerative Medicine - Video [Last Updated On: December 9th, 2011] [Originally Added On: December 9th, 2011]
- 059 StemCellTV Talks to Michael Werner of Alliance for Regenerative Medicine at Meeting on the Mesa - Video [Last Updated On: December 10th, 2011] [Originally Added On: December 10th, 2011]
- 060 StemCellTV Talks to Morrie Ruffin of Alliance for Regenerative Medicine at Meeting on the Mesa - Video [Last Updated On: December 10th, 2011] [Originally Added On: December 10th, 2011]
- 061 Active phase III or II/III cell therapy trials [Last Updated On: December 11th, 2011] [Originally Added On: December 11th, 2011]
- 062 Active phase III or II/III cell therapy trials [Last Updated On: December 11th, 2011] [Originally Added On: December 11th, 2011]
- 063 2011 Summit: Harnessing Regenerative Medicine for US Service-members, Major General James K. Gilman - Video [Last Updated On: December 17th, 2011] [Originally Added On: December 17th, 2011]
- 064 Recently approved cell therapy products [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- 065 Inactive and recently failed or terminated phase III or II/III cell therapy trials [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- 066 Recently approved cell therapy products [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- 067 Inactive and recently failed or terminated phase III or II/III cell therapy trials [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- 068 Coast To Coast AM: 15.11.2011 - Regenerative Medicine/ Dulce Base - Video [Last Updated On: December 22nd, 2011] [Originally Added On: December 22nd, 2011]
- 069 Stem Cell Clinical Trial for Heart Failure: Eduardo Marban - CIRM Spotlight on Disease - Video [Last Updated On: December 23rd, 2011] [Originally Added On: December 23rd, 2011]
- 070 2011 EMA Committee for Advanced Therapies (CAT) classification record. What can be learned? [Last Updated On: January 1st, 2012] [Originally Added On: January 1st, 2012]
- 071 2011 EMA Committee for Advanced Therapies (CAT) classification record. What can be learned? [Last Updated On: January 1st, 2012] [Originally Added On: January 1st, 2012]
- 072 Regenerative medicine company encouraged by heart failure trial [Last Updated On: January 28th, 2012] [Originally Added On: January 28th, 2012]
- 073 IndiaMART Leaders of Tomorrow AWards 2011 - Regenerative Medical Services Pvt Ltd - Video [Last Updated On: February 8th, 2012] [Originally Added On: February 8th, 2012]
- 074 American CryoStem Joins Alliance for Regenerative Medicine [Last Updated On: February 13th, 2012] [Originally Added On: February 13th, 2012]
- 075 ACT Announces Third Patient with Stargardt’s Disease Treated in U.S. Clinical Trial with RPE Cells Derived from ... [Last Updated On: February 14th, 2012] [Originally Added On: February 14th, 2012]
- 076 Biomask: Improving Facial Burn Treatment for Soldiers in the Field [Last Updated On: February 17th, 2012] [Originally Added On: February 17th, 2012]
- 077 Cytomedix to Showcase Aldagen's Promising Autologous Cell Therapy Technology at Two Regenerative Medicine Meetings [Last Updated On: February 17th, 2012] [Originally Added On: February 17th, 2012]
- 078 Histogenics to Present at 7th Annual New York Stem Cell Summit [Last Updated On: February 17th, 2012] [Originally Added On: February 17th, 2012]
- 079 BioTime CEO Michael D. West to Present at New York Stem Cell Summit [Last Updated On: February 18th, 2012] [Originally Added On: February 18th, 2012]
- 080 Makucell(TM) Announces Key Scientific Presentations and Launch of a Large, Multicenter Use Study of Asymmtate(TM) [Last Updated On: February 22nd, 2012] [Originally Added On: February 22nd, 2012]